Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

477 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
First-line pembrolizumab-axitinib versus sunitinib in metastatic RCC: subgroup analysis of patients enrolled in the phase 3 KEYNOTE-426 in Eastern Asia.
Chung HJ, Kondoh C, Bae WK, Tamada S, Matsubara N, Lee HJ, Mizuno R, Anai S, Kimura G, Tomita Y, Chang CH, Chang JW, Lin J, Perini RF, Molife LR, Powles T, Rini BI, Uemura H. Chung HJ, et al. Among authors: mizuno r. Jpn J Clin Oncol. 2025 Jan 16:hyae182. doi: 10.1093/jjco/hyae182. Online ahead of print. Jpn J Clin Oncol. 2025. PMID: 39815637
Prognostic value of PD-L1 expression in recurrent renal cell carcinoma after nephrectomy: a secondary analysis of the ARCHERY study.
Tamada S, Nozawa M, Ohba K, Mizuno R, Takamoto A, Ohe C, Yoshimoto T, Nakagawa Y, Fukuyama T, Matsubara N, Kimura G, Tomita Y, Nonomura N, Eto M. Tamada S, et al. Among authors: mizuno r. Int J Clin Oncol. 2023 Feb;28(2):289-298. doi: 10.1007/s10147-022-02256-z. Epub 2022 Dec 19. Int J Clin Oncol. 2023. PMID: 36534263 Free PMC article.
Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma.
Choueiri TK, Powles T, Burotto M, Escudier B, Bourlon MT, Zurawski B, Oyervides Juárez VM, Hsieh JJ, Basso U, Shah AY, Suárez C, Hamzaj A, Goh JC, Barrios C, Richardet M, Porta C, Kowalyszyn R, Feregrino JP, Żołnierek J, Pook D, Kessler ER, Tomita Y, Mizuno R, Bedke J, Zhang J, Maurer MA, Simsek B, Ejzykowicz F, Schwab GM, Apolo AB, Motzer RJ; CheckMate 9ER Investigators. Choueiri TK, et al. Among authors: mizuno r. N Engl J Med. 2021 Mar 4;384(9):829-841. doi: 10.1056/NEJMoa2026982. N Engl J Med. 2021. PMID: 33657295 Free PMC article. Clinical Trial.
Multiple Immune-Related Adverse Events and Anti-Tumor Efficacy: Real-World Data on Various Solid Tumors.
Shimozaki K, Sukawa Y, Beppu N, Kurihara I, Suzuki S, Mizuno R, Funakoshi T, Ikemura S, Tsugaru K, Togasaki K, Kawasaki K, Hirata K, Hayashi H, Hamamoto Y, Takaishi H, Kanai T. Shimozaki K, et al. Among authors: mizuno r. Cancer Manag Res. 2020 Jun 16;12:4585-4593. doi: 10.2147/CMAR.S247554. eCollection 2020. Cancer Manag Res. 2020. PMID: 32606951 Free PMC article.
The Entire Intestinal Tract Surveillance Using Capsule Endoscopy after Immune Checkpoint Inhibitor Administration: A Prospective Observational Study.
Shimozaki K, Hirata K, Horie S, Chida A, Tsugaru K, Hayashi Y, Kawasaki K, Miyanaga R, Hayashi H, Mizuno R, Funakoshi T, Hosoe N, Hamamoto Y, Kanai T. Shimozaki K, et al. Among authors: mizuno r. Diagnostics (Basel). 2021 Mar 18;11(3):543. doi: 10.3390/diagnostics11030543. Diagnostics (Basel). 2021. PMID: 33803735 Free PMC article.
Colorectal anastomotic leakage after conversion surgery for advanced endometrial cancer treated with lenvatinib plus pembrolizumab: a case report.
Yamamura A, Hamanishi J, Yamanoi K, Sunada M, Taki M, Mizuno R, Okada Y, Murakami R, Aisu Y, Maekawa H, Yamaguchi K, Mandai M. Yamamura A, et al. Among authors: mizuno r. Int Cancer Conf J. 2024 Dec 10;14(1):64-71. doi: 10.1007/s13691-024-00739-6. eCollection 2025 Jan. Int Cancer Conf J. 2024. PMID: 39758791 Free PMC article.
477 results